Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleter
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the pers
| Agency | National Institutes of Health |
|---|---|
| Status | Posted |
| Opportunity number | RFA-DA-26-034 |
| Posted date | 11/20/2024 |
| Application deadline | Nov 18, 2027 12:00:00 AM EST |
| Award ceiling | 300,000 |
| Award floor | none |
| Estimated total funding | 300,000 |
| Who can apply | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); R |
| Assistance Listing (CFDA) | 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838 |
| Description | This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents. |
| Agency contact | grantsinfo@nih.gov |
| Official listing | https://www.grants.gov/search-results-detail/357250 |